Latest Articles

Publication Date
Robotic-assisted laparoscopy increases endometrial cancer survival rates - Contemporary Obgyn

Robotic-assisted laparoscopy increases endometrial cancer survival rates Contemporary Obgyn

Published: March 13, 2025, 5:15 p.m.
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients - Nature.com

Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients Nature.com

Published: March 6, 2025, 6:11 a.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) - Frontiers

Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) Frontiers

Published: Feb. 24, 2025, 1:38 p.m.
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly

Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly

Published: Feb. 4, 2025, 11:09 a.m.
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer - OncLive

Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:54 p.m.
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - Medscape

Does Chemoradiotherapy Boost Survival in Endometrial Cancer? Medscape

Published: Jan. 21, 2025, 9:45 a.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - Physician's Weekly

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer Physician's Weekly

Published: Oct. 22, 2024, 6:31 a.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - HealthDay

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer HealthDay

Published: Oct. 21, 2024, 3:35 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!